Trial Condition(s):

Diabetes Mellitus

GlucoFriend-evaluation the effectiveness of Glucobay when combined with a basal insulin

Bayer Identifier:

15316

ClinicalTrials.gov Identifier:

NCT01248481

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.

Inclusion Criteria
- Signed written informed consent
 - Age ≥ 18 years   
 - Diagnosed of type 2 diabetes for at least 6 months prior to enrollment
 - Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months
 - HbA1C≥7.5 and ≤10.0%
Exclusion Criteria
- Exclusion criteria must be read in conjunction with the local product information

Trial Summary

Enrollment Goal
539
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, South Korea

Status
Completed

Trial Design